Preferred treatment and prevention strategies for recurrent community-associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: a survey of adult and pediatric providers

Am J Infect Control. 2010 May;38(4):324-8. doi: 10.1016/j.ajic.2009.11.007.

Abstract

Among pediatric and adult providers, 70% preferred trimethoprim-sulfamethoxazole for directed treatment of community-associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infections, although a higher proportion of pediatric compared with adult providers favored clindamycin (36% vs 8%, respectively, P < .0001). For recurrent infections, 88% of providers employed at least 1 topical decolonization strategy.

MeSH terms

  • Administration, Topical
  • Adult
  • Anti-Bacterial Agents / therapeutic use*
  • Antibiotic Prophylaxis / methods
  • Clindamycin / therapeutic use
  • Community-Acquired Infections / drug therapy*
  • Community-Acquired Infections / microbiology
  • Humans
  • Methicillin-Resistant Staphylococcus aureus / isolation & purification*
  • Recurrence
  • Soft Tissue Infections / drug therapy*
  • Soft Tissue Infections / microbiology
  • Staphylococcal Infections / drug therapy*
  • Staphylococcal Infections / microbiology
  • Staphylococcal Skin Infections / drug therapy*
  • Staphylococcal Skin Infections / microbiology
  • Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Clindamycin
  • Trimethoprim, Sulfamethoxazole Drug Combination